Eloxatin Sales Data
Last updated: February 2014 (updated quarterly).
The following data shows Eloxatin U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q3 2012 | 78 ( 49) |
$203,067 | -55.33% | 128 | -54.45% |
| Q2 2012 | 29 ( 2) |
$454,567 | 5.24% | 281 | 2.55% |
| Q1 2012 | 31 (4) |
$431,928 | 8.38% | 274 | 5.79% |
| Q4 2011 | 35 (4) |
$398,541 | 12.60% | 259 | 9.75% |
| Q3 2011 | 39 (16) |
$353,940 | 34.41% | 236 | 29.67% |
| Q2 2011 | 55 ( ) |
$263,326 | n/a | 182 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
